Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 83 Breast Neoplasms 55 Prostatic Neoplasms 40 Lung Neoplasms 35 Multiple Myeloma 34 Neoplasms 26 Colorectal Neoplasms 23 Leukemia, Lymphocytic, Chronic, B-Cell 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Neoplasm Metastasis 20 Ovarian Neoplasms 18 Carcinoma, Renal Cell 16 Urinary Bladder Neoplasms 13 Small Cell Lung Carcinoma 13 Pancreatic Neoplasms 13 Myasthenia Gravis 12 Leukemia, Myeloid, Acute 12 Endometrial Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Nasopharyngeal Carcinoma 11 Stomach Neoplasms 10 Non-Muscle Invasive Bladder Neoplasms 10 Recurrence 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 9 Fallopian Tube Neoplasms 9 Triple Negative Breast Neoplasms 8 Colonic Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 7 Burkitt Lymphoma 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Large B-cell Lymphoma × 30 days × Clear all

NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡